Prodermic TXA.sr is a premium melasma maintenance serum that targets pigmentation through a fundamentally different pathway than acid-based or standard brightening approaches.Tranexamic Acid 5% blocks the hormonal and UV-triggered signals that cause pigmentation in the first place. Azelaic Acid 3% provides anti-inflammatory and pigment-reducing dual action. Niacinamide 10% stops pigment transfer from pigment-producing cells to surrounding skin cells. Hyaluronic Acid 1% maintains barrier hydration. Total active load: 19%.Addresses hormonal and vascular components of melasma that conventional agents cannot reach. ~75 sessions per 30ml bottle.





TANH-4 Complex — Tranexamic Acid 5% with azelaic acid anti-inflammatory action, niacinamide pigment-transfer blocking, and hyaluronic acid barrier support.Tranexamic Acid 5% blocks the UV-triggered and hormonal signaling cascade that tells pigment cells to produce melanin, interrupting the cause of pigmentation at its source. Azelaic Acid 3% provides anti-inflammatory action while selectively targeting overactive pigment cells. Niacinamide 10% stops pigment transfer to prevent visible discoloration even when melanin is produced. Hyaluronic Acid 1% ensures barrier health during continuous depigmentation.A completely different approach to melasma — addresses the root triggers, not just the symptoms.
Recommended sequence for prodermic TXA.sr. Frequency: Daily (AM/PM).
Hormonal melasma, recurrent melasma despite peel treatment, patients on hormonal medication, premium upsell for severe melasma cases